Clinical Topics & News
News
ED Visits for Diabetes on the Rise in the US
The most ED visits were made by patients with diabetes and two to four other chronic conditions.
News
ADA issues new screening, obesity management recommendations
Two new recommendations have been added to include screening of adults with diabetes for asymptomatic heart failure by measuring natriuretic...
News
T2D: Real benefits of new oral antidiabetic drugs
What about in the real world? Could combining SGLT2 inhibitors with GLP-1R agonists be even more effective?
News
Semaglutide prescribing surged in the past year
General and family practice providers were the most frequent semaglutide providers (30%), followed by internists (15%).
Conference Coverage
Antidepressants ‘don’t blunt’ semaglutide and weight loss
“Semaglutide 2.4 mg provides an effective treatment option for weight management, regardless of antidepressant use at baseline.”
News
Taking a new obesity drug and birth control pills? Be careful
“It [the warning] was in the product insert, but clinically speaking, I don’t know if it was at the top of providers’ minds when they were...
News
FDA panel rejects implanted GLP1-RA dosing device for T2D
“The data show concerning safety signals that need further investigation.”
News
Exercise timing may dictate obesity, type 2 diabetes risk
People who exercised in the morning had a lower body mass index than those who exercised at other times, even though they were more sedentary.
News
FDA clears new capabilities for diabetes app BlueStar
The clearance enables the app-based platform to provide bolus insulin dose recommendations that are based on glucose and trend data from a...
News
Lower is better for blood glucose to reduce heart disease
“We uncovered compelling evidence that for blood sugar levels within the ‘normal’ range, it was a case of ‘the lower the better’ in protecting...